Volume 92 Issue 50 | pp. 28-30
Issue Date: December 15, 2014

Confronting Irreproducibility In Life Sciences Research

Community takes steps to improve the quality and reproducibility of drug discovery and biomarker studies
Department: Science & Technology
Keywords: reproducibility, life sciences, biomarkers, biospecimens, journals

Reproducibility is a hallmark of science—at least, it’s supposed to be. Over the past several years, it’s become increasingly apparent that many lab studies, especially in the life sciences, are not reproducible. As a result, many putative drug targets or diagnostic biomarkers can’t be validated. Some estimates suggest that more than 50% of all published life sciences research is irreproducible, and some indicate that the figure might be even higher.

The problem flew below the . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society